Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CLLS

Cellectis (CLLS)

Cellectis SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLLS
DateTimeSourceHeadlineSymbolCompany
29/06/202406:30GlobeNewswire Inc.Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024NASDAQ:CLLSCellectis SA
21/06/202406:30GlobeNewswire Inc.Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base EditingNASDAQ:CLLSCellectis SA
13/06/202406:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
13/06/202406:30GlobeNewswire Inc.Cellectis Unveils a Non-Viral Gene Therapy Approach for Sickle Cell Disease in Nature CommunicationsNASDAQ:CLLSCellectis SA
05/06/202406:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
05/06/202406:30GlobeNewswire Inc.Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic LeukemiaNASDAQ:CLLSCellectis SA
30/05/202406:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
30/05/202406:30GlobeNewswire Inc.Cellectis’ Annual Shareholders General Meeting to be Held on June 28, 2024NASDAQ:CLLSCellectis SA
29/05/202406:30GlobeNewswire Inc.Cellectis Reports Financial Results for First Quarter 2024NASDAQ:CLLSCellectis SA
28/05/202420:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
28/05/202406:30GlobeNewswire Inc.Cellectis to Report First Quarter 2024 Financial Results on May 28, 2024NASDAQ:CLLSCellectis SA
25/05/202406:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
06/05/202420:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
06/05/202416:00GlobeNewswire Inc.Cellectis Announces Completion of the Additional Equity Investment by AstraZenecaNASDAQ:CLLSCellectis SA
03/05/202406:30GlobeNewswire Inc.Cellectis Appoints Arthur Stril as Interim Chief Financial OfficerNASDAQ:CLLSCellectis SA
30/04/202406:46GlobeNewswire Inc.Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023NASDAQ:CLLSCellectis SA
23/04/202406:30GlobeNewswire Inc.Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCsNASDAQ:CLLSCellectis SA
11/04/202406:30GlobeNewswire Inc.Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCsNASDAQ:CLLSCellectis SA
09/04/202406:30GlobeNewswire Inc.Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and Gene Insertion in HSPCs at the ASGCT Annual MeetingNASDAQ:CLLSCellectis SA
17/01/202408:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
17/01/202408:30GlobeNewswire Inc.Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agreement entered with the European Investment Bank (EIB)NASDAQ:CLLSCellectis SA
23/12/202308:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
23/12/202308:30GlobeNewswire Inc.Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023NASDAQ:CLLSCellectis SA
23/12/202308:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
06/12/202308:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
18/11/202308:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
18/11/202308:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
18/11/202308:30GlobeNewswire Inc.Cellectis’ Shareholders Meeting to be Held on December 22, 2023NASDAQ:CLLSCellectis SA
15/11/202323:48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CLLSCellectis SA
15/11/202318:30GlobeNewswire Inc.Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZenecaNASDAQ:CLLSCellectis SA
 Showing the most relevant articles for your search:NASDAQ:CLLS

Your Recent History

Delayed Upgrade Clock